JP2014501714A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014501714A5 JP2014501714A5 JP2013538264A JP2013538264A JP2014501714A5 JP 2014501714 A5 JP2014501714 A5 JP 2014501714A5 JP 2013538264 A JP2013538264 A JP 2013538264A JP 2013538264 A JP2013538264 A JP 2013538264A JP 2014501714 A5 JP2014501714 A5 JP 2014501714A5
- Authority
- JP
- Japan
- Prior art keywords
- bifunctional
- molecular
- group
- composition according
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1019118.7 | 2010-11-11 | ||
| GB201019118A GB201019118D0 (en) | 2010-11-11 | 2010-11-11 | Conjugates and their uses in molecular imaging |
| PCT/GB2011/001599 WO2012063028A1 (en) | 2010-11-11 | 2011-11-11 | Conjugates and their uses in molecular imaging |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014501714A JP2014501714A (ja) | 2014-01-23 |
| JP2014501714A5 true JP2014501714A5 (enExample) | 2014-12-25 |
| JP5986095B2 JP5986095B2 (ja) | 2016-09-06 |
Family
ID=43431334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013538264A Active JP5986095B2 (ja) | 2010-11-11 | 2011-11-11 | コンジュゲートおよび分子イメージングにおけるそれらの用途 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9138495B2 (enExample) |
| EP (1) | EP2637705B1 (enExample) |
| JP (1) | JP5986095B2 (enExample) |
| AU (1) | AU2011327931B2 (enExample) |
| ES (1) | ES2625829T3 (enExample) |
| GB (1) | GB201019118D0 (enExample) |
| WO (1) | WO2012063028A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7098442B2 (en) | 2003-03-05 | 2006-08-29 | Raytheon Company | Thin micropolarizing filter, and a method for making it |
| CA2830349C (en) | 2011-03-17 | 2019-07-16 | The University Of Birmingham | Re-directed immunotherapy |
| EP4147724A1 (en) | 2013-10-31 | 2023-03-15 | Beth Israel Deaconess Medical Center | Near-infrared fluorescent contrast bioimaging agents and methods of use thereof |
| US11001562B2 (en) | 2013-10-31 | 2021-05-11 | Beth Israel Deaconess Medical Center | Near-infrared fluorescent nerve contrast agents and methods of use thereof |
| GB201417067D0 (en) | 2014-09-26 | 2014-11-12 | South African Nuclear Energy | Radiopharmaceutical conjugate |
| GB201504064D0 (en) * | 2015-03-10 | 2015-04-22 | Accretion Biotechnology Ltd | Method and kits for preparing radionuclide complexes |
| JP7253762B2 (ja) * | 2017-12-27 | 2023-04-07 | 慈濟大學 | タンパク質を表面に発現させた小胞によるオートファジー細胞およびアポトーシス細胞への薬剤送達 |
| US20250082795A1 (en) | 2023-09-12 | 2025-03-13 | Curadel Surgical Innovations, Inc. | Combinations of imaging agent conjugates and application thereof |
| CN120590625A (zh) * | 2024-11-06 | 2025-09-05 | 江苏申命医疗科技有限公司 | 一种放射性核素标记的聚合物、其制备方法及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| EP0672142B1 (en) | 1992-12-04 | 2001-02-28 | Medical Research Council | Multivalent and multispecific binding proteins, their manufacture and use |
| AU2865995A (en) | 1995-06-14 | 1997-01-15 | Regents Of The University Of California, The | 3-hydroxy-2(1h)-pyridinone chelating agents |
| WO2007042504A2 (fr) * | 2005-10-07 | 2007-04-19 | Guerbet | Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium |
| US8158804B2 (en) | 2007-01-11 | 2012-04-17 | Ge Healthcare As | Chelating agents |
| US8475768B2 (en) | 2007-08-13 | 2013-07-02 | Ge Healthcare As | Paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (MRI) |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
-
2010
- 2010-11-11 GB GB201019118A patent/GB201019118D0/en not_active Ceased
-
2011
- 2011-11-11 ES ES11788554.1T patent/ES2625829T3/es active Active
- 2011-11-11 AU AU2011327931A patent/AU2011327931B2/en active Active
- 2011-11-11 EP EP11788554.1A patent/EP2637705B1/en active Active
- 2011-11-11 WO PCT/GB2011/001599 patent/WO2012063028A1/en not_active Ceased
- 2011-11-11 JP JP2013538264A patent/JP5986095B2/ja active Active
- 2011-11-11 US US13/884,660 patent/US9138495B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014501714A5 (enExample) | ||
| JP7393485B2 (ja) | 前立腺特異的膜抗原（ｐｓｍａ）の標識インヒビター、前立腺癌の治療のための画像化剤および薬剤としてのその使用 | |
| CN108541302B (zh) | 用于成像和治疗的尿素基前列腺特异性膜抗原(psma)抑制剂 | |
| Bandari et al. | Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN (7-14) NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer | |
| AU2017382282B9 (en) | Tumor and immune cell imaging based on PD-L1 expression | |
| JP2020203893A (ja) | Ｐｓｍａを標的としたイメージング及び放射線治療のための金属／放射性金属標識ｐｓｍａ阻害剤 | |
| Yan et al. | Peptide heterodimers for molecular imaging | |
| JP4948742B2 (ja) | ペプチド系化合物 | |
| Cheng et al. | 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors | |
| CA3071315A1 (en) | Dual mode radiotracer and -therapeutics | |
| Velikyan | Positron emitting [68Ga] Ga-based imaging agents: chemistry and diversity | |
| Imberti et al. | Enhancing PET signal at target tissue in vivo: dendritic and multimeric tris (hydroxypyridinone) conjugates for molecular imaging of αvβ3 integrin expression with gallium-68 | |
| Perols et al. | Influence of DOTA chelator position on biodistribution and targeting properties of 111In-labeled synthetic anti-HER2 affibody molecules | |
| JP2014503546A (ja) | 放射性標識ｈｅｒ２結合ペプチド | |
| Kuil et al. | Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression | |
| JP2018524352A (ja) | Ｈｂｅｄ−ビスホスホネート、その放射性金属コンジュゲート、およびセラノスティック剤としてのそれらの使用 | |
| Sun et al. | Preclinical study on GRPR-targeted 68Ga-probes for PET imaging of prostate cancer | |
| JP2018524352A5 (enExample) | ||
| Ma et al. | Gallium-68 complex of a macrobicyclic cage amine chelator tethered to two integrin-targeting peptides for diagnostic tumor imaging | |
| Maresca et al. | Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC) | |
| CN104830316B (zh) | 一种用于核素标记的靶向探针及其制备方法和应用 | |
| Farzin et al. | Clinical aspects of radiolabeled aptamers in diagnostic nuclear medicine: A new class of targeted radiopharmaceuticals | |
| Ruan et al. | Synthesis and preclinical evaluation of novel 99mTc-labeled FAPI-46 derivatives with significant tumor uptake and improved tumor-to-nontarget ratios | |
| Braun et al. | Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αvβ3 Targeting | |
| Ganguly et al. | Evaluation of copper-64-labeled αvβ6-targeting peptides: addition of an albumin binding moiety to improve pharmacokinetics |